证券记录 · 已归档季度
IOVA
Iovance Biotherapeutics, Inc. · Healthcare · Biotechnology
10被追踪持有人
—Δ持有人
13.79M持有股份
$110.63M报告持仓市值
+0新建仓位
−0清仓
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 103 | +5 | 196.52M | $817.32M | +8 | −3 |
| Q1 2026 | 101 | +2 | 181.45M | $636.15M | +8 | −6 |
| Q4 2025 | 98 | +1 | 178.19M | $486.45M | +1 | — |
| Q3 2025 | 14 | -2 | 98.05M | $212.78M | — | −2 |
| Q2 2025 | 13 | -2 | 89.90M | $154.64M | — | −2 |
| Q1 2025 | 12 | +2 | 25.73M | $85.68M | +2 | — |
| Q4 2024 | 10 | 0 | 23.63M | $174.86M | +2 | −2 |
| Q3 2024 | 9 | -1 | 11.04M | $103.72M | +1 | −2 |
| Q2 2024 | 10 | — | 13.79M | $110.63M | — | — |
持有人 · Q2 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (被动) | 5.79M | — | $46.42M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (被动) | 5.79M | — | $46.42M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 3.48M | — | $27.93M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 3.48M | — | $27.93M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Marshall Wace ✦ | 1.61M | — | $12.93M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Marshall Wace ✦ | 1.61M | — | $12.93M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Norges Bank ✦ (被动) | 942.98K | — | $7.56M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Two Sigma Investments ✦ | 774.78K | — | $6.21M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | D. E. Shaw & Co. ✦ | 655.83K | — | $5.26M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 243.26K | — | $1.95M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Millennium Management ✦ | 166.15K | — | $1.33M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Wellington Management ✦ | 117.42K | — | $941,693 | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Wellington Management ✦ | 117.42K | — | $941,693 | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Wellington Management ✦ | 117.42K | — | $941,693 | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Wellington Management ✦ | 117.42K | — | $941,693 | 0.0% | n/c | 1 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 11.48K | — | $92,045 | 0.0% | n/c | 1 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 11.48K | — | $92,045 | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 282 持有人, 266.49M 股份, $901.79M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
Aug 07
SC 13G — STATE STREET CORP
Jul 28
SC 13G/A — BlackRock, Inc.
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2024 ·
方法论 ·
通过API获取此数据